These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 31059266)
1. Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics. Chen X; Lu D; Gao J; Zhu H; Zhou Y; Gao D; Zhou H J Proteome Res; 2019 Jun; 18(6):2654-2665. PubMed ID: 31059266 [TBL] [Abstract][Full Text] [Related]
2. USP9X stabilizes BRCA1 and confers resistance to DNA-damaging agents in human cancer cells. Lu Q; Zhang FL; Lu DY; Shao ZM; Li DQ Cancer Med; 2019 Nov; 8(15):6730-6740. PubMed ID: 31512408 [TBL] [Abstract][Full Text] [Related]
3. Deubiquitinase ubiquitin-specific protease 9X regulates the stability and function of E3 ubiquitin ligase ring finger protein 115 in breast cancer cells. Lu Q; Lu D; Shao ZM; Li DQ Cancer Sci; 2019 Apr; 110(4):1268-1278. PubMed ID: 30689267 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis. Liu Y; Xu X; Lin P; He Y; Zhang Y; Cao B; Zhang Z; Sethi G; Liu J; Zhou X; Mao X J Biol Chem; 2019 Mar; 294(12):4572-4582. PubMed ID: 30718275 [TBL] [Abstract][Full Text] [Related]
5. A novel USP9X substrate TTK contributes to tumorigenesis in non-small-cell lung cancer. Chen X; Yu C; Gao J; Zhu H; Cui B; Zhang T; Zhou Y; Liu Q; He H; Xiao R; Huang R; Xie H; Gao D; Zhou H Theranostics; 2018; 8(9):2348-2360. PubMed ID: 29721084 [TBL] [Abstract][Full Text] [Related]
6. Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growth. Yang B; Zhang S; Wang Z; Yang C; Ouyang W; Zhou F; Zhou Y; Xie C Oncotarget; 2016 Nov; 7(48):79515-79525. PubMed ID: 27783990 [TBL] [Abstract][Full Text] [Related]
7. USP9X controls translation efficiency via deubiquitination of eukaryotic translation initiation factor 4A1. Li Z; Cheng Z; Raghothama C; Cui Z; Liu K; Li X; Jiang C; Jiang W; Tan M; Ni X; Pandey A; Liu JO; Dang Y Nucleic Acids Res; 2018 Jan; 46(2):823-839. PubMed ID: 29228324 [TBL] [Abstract][Full Text] [Related]
8. The X-linked deubiquitinase USP9X is an integral component of centrosome. Wang Q; Tang Y; Xu Y; Xu S; Jiang Y; Dong Q; Zhou Y; Ge W J Biol Chem; 2017 Aug; 292(31):12874-12884. PubMed ID: 28620049 [TBL] [Abstract][Full Text] [Related]
9. Targeting USP9x/SOX2 axis contributes to the anti-osteosarcoma effect of neogambogic acid. Chen X; Zhang X; Cai H; Yang W; Lei H; Xu H; Wang W; Zhu Q; Kang J; Yin T; Gu W; Wu YL Cancer Lett; 2020 Jan; 469():277-286. PubMed ID: 31605775 [TBL] [Abstract][Full Text] [Related]
10. USP9X regulates the proliferation, survival, migration and invasion of gastric cancer cells by stabilizing MTH1. Xu W; Zhang Y; Su Y; Li L; Yang X; Wang L; Gao H BMC Gastroenterol; 2024 Jul; 24(1):239. PubMed ID: 39075342 [TBL] [Abstract][Full Text] [Related]
11. USP9X promotes apoptosis in cholangiocarcinoma by modulation expression of KIF1Bβ via deubiquitinating EGLN3. Chen W; Song J; Liu S; Tang B; Shen L; Zhu J; Fang S; Wu F; Zheng L; Qiu R; Chen C; Gao Y; Tu J; Zhao Z; Ji J J Biomed Sci; 2021 Jun; 28(1):44. PubMed ID: 34112167 [TBL] [Abstract][Full Text] [Related]
12. DDX3 interacts with USP9X and participates in deubiquitination of the anti-apoptotic protein MCL1. Lai MC; Chen YP; Li DA; Yu JS; Hung HY; Tarn WY FEBS J; 2022 Feb; 289(4):1043-1061. PubMed ID: 34606682 [TBL] [Abstract][Full Text] [Related]
14. Targeting of the deubiquitinase USP9X attenuates B-cell acute lymphoblastic leukemia cell survival and overcomes glucocorticoid resistance. Zhou M; Wang T; Lai H; Zhao X; Yu Q; Zhou J; Yang Y Biochem Biophys Res Commun; 2015 Apr; 459(2):333-339. PubMed ID: 25735983 [TBL] [Abstract][Full Text] [Related]
15. Deubiquitinase USP9X stabilizes RNA m Wang P; Wang J; Yao S; Cui M; Cheng Y; Liu W; Gao Z; Hu J; Zhang J; Zhang H J Biol Chem; 2023 Aug; 299(8):105055. PubMed ID: 37454738 [TBL] [Abstract][Full Text] [Related]
16. USP9X destabilizes pVHL and promotes cell proliferation. Zhang C; Peng Z; Zhu M; Wang P; Du X; Li X; Liu Y; Jin Y; McNutt MA; Yin Y Oncotarget; 2016 Sep; 7(37):60519-60534. PubMed ID: 27517496 [TBL] [Abstract][Full Text] [Related]
17. Noxa controls Mule-dependent Mcl-1 ubiquitination through the regulation of the Mcl-1/USP9X interaction. Gomez-Bougie P; Ménoret E; Juin P; Dousset C; Pellat-Deceunynck C; Amiot M Biochem Biophys Res Commun; 2011 Sep; 413(3):460-4. PubMed ID: 21907705 [TBL] [Abstract][Full Text] [Related]
18. Deubiquitylase USP9X maintains centriolar satellite integrity by stabilizing pericentriolar material 1 protein. Han KJ; Wu Z; Pearson CG; Peng J; Song K; Liu CW J Cell Sci; 2019 Jan; 132(2):. PubMed ID: 30584065 [TBL] [Abstract][Full Text] [Related]
19. Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies. Peterson LF; Sun H; Liu Y; Potu H; Kandarpa M; Ermann M; Courtney SM; Young M; Showalter HD; Sun D; Jakubowiak A; Malek SN; Talpaz M; Donato NJ Blood; 2015 Jun; 125(23):3588-97. PubMed ID: 25814533 [TBL] [Abstract][Full Text] [Related]
20. Usp9x Promotes Survival in Human Pancreatic Cancer and Its Inhibition Suppresses Pancreatic Ductal Adenocarcinoma In Vivo Tumor Growth. Pal A; Dziubinski M; Di Magliano MP; Simeone DM; Owens S; Thomas D; Peterson L; Potu H; Talpaz M; Donato NJ Neoplasia; 2018 Feb; 20(2):152-164. PubMed ID: 29248719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]